(CIDRAP News) – An annual report released yesterday by the US Centers for Disease Control and Prevention (CDC) profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.
(CIDRAP News) The World Health Organization (WHO) tally of human cases of H5N1 avian influenza rose to 161, including 86 deaths, with the final confirmation of 12 cases in Turkey and one in Iraq this week.